Obesity‐related sleep breathing disorders such as obstructive sleep apnea (OSA) and
obesity hypoventilation syndrome (OHS) cause intermittent hypoxia (IH) during sleep, a …

Obstructive sleep apnoea (OSA) is associated with cardiovascular and metabolic
comorbidities, including hypertension, dyslipidaemia, insulin resistance and atherosclerosis …

Although commonly observed in clinical practice, the heterogeneity of obstructive sleep
apnoea (OSA) clinical presentation has not been formally characterised. This study was the …

Abstract Study Objectives Distinct clinical phenotypes of obstructive sleep apnea (OSA)
have been identified: Disturbed Sleep, Minimally Symptomatic, and Sleepy. Determining …

Abstract Study Objectives This study evaluated differences in upper airway, soft tissues and
craniofacial structures between Asians from China and Europeans from Iceland with OSA …

The dramatic increases in incidence of both obesity and many cancers including skin cancer
emphasize the need to better understand the pathophysiology of both conditions and their …

Obstructive sleep apnea (OSA) and asthma are highly prevalent respiratory disorders and
are frequently co-morbid. Risk factors common to the two diseases include obesity, rhinitis …

Obstructive sleep apnea (OSA) consists of sleep-related repetitive obstructions of upper
airways that generate episodes of recurrent or intermittent hypoxia (IH). OSA commonly …

Leptin is a peptide hormone produced mainly in white adipose tissue. It is known to regulate
energy homeostasis, inflammation, metabolism, and sympathetic nerve activity. Increasing …

Introduction The recent continuous positive airway pressure (CPAP) crisis has highlighted
the need for alternative obstructive sleep apnea (OSA) therapies. This article serves to …